MedTrace Logo

NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure

NCT01227122 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-03-04

No results posted yet for this study

Summary

Primary endpoint: To evaluate predictive value of plasmatic levels of Neutrophil Gelatinase Associated Lipocalin (NGAL) to reveal acute kidney failure after cardiac surgery in patients with preoperative chronic kidney failure Secondary endpoint is to obtain threshold values of NGAL.

Conditions

  • Preoperative KIDNEY FAILURE, CHRONIC
  • Postoperative KIDNEY FAILURE, ACUTE
  • Cardiac Surgical Procedures

Sponsors & Collaborators

  • Hopital Jean Minjoz

    lead OTHER

Principal Investigators

  • Chocron Sidney, MD, PhD · Centre Hospitalier Universitaire (CHU) Jean Minjoz, Besançon, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-07-31
Completion
2013-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01227122 on ClinicalTrials.gov